Google Accelerator is an initiative of the US giant to support the most promising technology projects. In the current edition, the Google Accelerator has focused on technologies that solve problems in modern medicine, healthcare and improving patient well-being.
As part of the program, Google provides executive training to help startups grow their business. The training includes theoretical part and workshops. Other important advantages are mentorship from Google engineers and outside experts as well as the opportunity to use Google’s technology facilities.
Among the fifteen companies from across Europe and Israel, it was MedApp that caught Google’s attention in the field of technology supporting diagnostic imaging and digital medicine of the future. The use of mixed reality, the creation of fully interactive 3D models from diagnostic imaging data, and the use of artificial intelligence as a tool to support patient diagnosis have given us the opportunity to stand out among other technology companies.
– “I hope the Accelerator’s mentorship will help scale our business to other countries and optimize the growth process, including entering new markets, conducting marketing or communicating with partners, investors and opinion leaders. The cooperation with Google for Startups Accelerator will clearly contribute to the improvement of MedApp’s competitiveness on the global market of innovative medical technology solutions,” says Krzysztof Mędrala, CEO of MedApp.
The Accelerator program will last until the end of the year and will be run by a team of experts from the Warsaw Google for Startups Campus. The 27 companies that have completed the course so far boast an average revenue growth of 74% year-on-year.
Read more See similar articles:
CarnaLife Holo with FDA (Food and Drugs Administration) certification for the US market!
We are proud to announce that our CarnaLile Holo technology for augmented reality imaging of medical data (interactive holograms) has received 510(k) Class II certification for the world’s largest and richest market for new technology and robotic technology.
MedApp after Q4 2022: continued development of digital medicine technology solutions and acquisition of new sales contacts
As in the previous quarters of 2022, the Company is observing an extension of sales processes in the Polish market, trying to shift sales activity to foreign markets. To this end, the Company has signed further distribution agreements for the CarnaLife Holo solution
We are looking for companies and individuals interested in distributing MedApp’s medical technology.
CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. With the help of Microsoft’s HoloLens 2, the physician can see in real space a three-dimensional hologram reflecting the structure of the imaged anatomical area.